Episode Five: Why CVS missed Aetna's hidden liabilities
In this episode, we examine the legal, regulatory, and reputational challenges that followed some of the largest transactions in the healthcare industry. From the Department of Justice's $117.7 million settlement with Aetna over allegations of Medicare Advantage coding practices to the antitrust conditions imposed on the $69 billion CVS Health–Aetna merger, we explore how regulators scrutinize deals long after they close.
We also discuss privacy-related litigation involving HIV medication records, allegations of broker kickback schemes, growing state oversight of pharmacy benefit managers, and the broader wave of accountability efforts that have reshaped the healthcare landscape in the wake of the opioid crisis.
Listen On
